Mick Peake, MD, of the University of Leicester, Leicester, UK, discusses the Collaboration for Oncology Data in Europe (CODE); an integrative effort to broaden our knowledge of anti-cancer drugs. He holds hope that CODE will provide us with information regarding the effectiveness of treatments for certain patients, improving patient outcomes and helping us to evaluate cancer treatments cost-efficiently. Finally, Prof. Peake shares his hopes that we can move towards a more integrative attitude to cancer treatment overall, focusing on pharmaceutical treatment in a broader context as opposed to a sole contributor of disease progression. This video was recorded at the UK Oncology Forum (OF), held in Liverpool, UK.
